We propose that this unprecedented role of SETD2 in the DDR constitutes a novel tumor suppressor mechanism that could explain the high frequency of SETD2 mutations found in several cancers and may provide an alternative mechanism for evasion of the p53-mediated checkpoint in TP53 wt ccRCC cells. This evidence concerns the gene TP53 and cancer.